KENNESAW, GA (August 2, 2021) – Deerland Probiotics & Enzymes has announced the publication of a new study that is the first of its kind to directly investigate the germination of a spore-forming probiotic strain in the human small intestines. The study, entitled Presence and germination of the probiotic Bacillus subtilis DE111® in the human small intestinal tract, has been published in Frontiers in Microbiology.
In a study involving female collegiate athletes during offseason training, researchers found that DE111 (1 billion CFU), in conjunction with…More
Combining the market growth of probiotics with the increasingly popular gummy delivery system is a market opportunity that shouldn’t be…More
Deerland Probiotics & Enzymes is pleased to announce that it has earned Non-GMO Project verification for its branded probiotic, DE111, as…More